The Foley urinary catheter has been used in the management of epistaxis for
many years, yet it has never been designed or licensed for this purpose. W
e performed a telephone questionnaire of senior house officers in 90 ENT de
partments in England and Wales. The aim was to determine how many departmen
ts used the Foley catheter for epistaxis management, whether licensed nasal
balloon devices were available and if there had been any complications ass
ociated with their use. Eighty-three (92%) ENT departments in the study use
d the Foley catheter for epistaxis management and 44 (49%) departments had
licensed balloon devices available. Only 22% of ENT senior house officers q
uestioned were aware that the Foley catheter was not licensed for use in th
e nose. Most complications associated with the use of nasal balloon devices
appear to be due to Foley catheters.